首页> 美国卫生研究院文献>Asian Pacific Journal of Cancer Prevention : APJCP >Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma
【2h】

Circulating MicroRNA-21 Expression as a Novel Serum Biomarker for Oral Sub-Mucous Fibrosis and Oral Squamous Cell Carcinoma

机译:循环MicroRNA-21表达作为口腔粘膜下纤维化和口腔鳞状细胞癌的新型血清生物标志物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Circulating miRNAs (miRs) in the biofluids such as serum and plasma act as potential biomarkers for early diagnosis, treatment and prognosis. In the present study, an attempt made to see the expression of miR-21 in serum of 20 cases of Oral sub-mucous fibrosis (OSMF), 20 cases of Oral squamous cell carcinoma and 40 healthy volunteers. The expression of miR-21 was evaluated in relation to different demographical and clinicopathological features such as sex, tobacco, pan-masala, alcohol, smoking and clinical staging respectively with an aim to identify correlation with oral pre-cancer and cancer stages.
机译:背景:诸如血清和血浆等生物流体中的循环miRNA(miR)可作为早期诊断,治疗和预后的潜在生物标志物。在本研究中,试图观察miR-21在20例口腔粘膜下纤维化(OSMF),20例口腔鳞状细胞癌和40名健康志愿者的血清中的表达。分别针对不同的人口统计学和临床​​病理特征(例如性别,烟草,泛马萨拉,酒精,吸烟和临床分期)评估了miR-21的表达,目的是确定与口腔癌前期和癌症分期的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号